The anesthetic management and the specific features of perioperative management in cases of nephrectomy with thrombectomy from the inferior vena cava in patients with renal cell cancer

Cover Page

Cite item

Abstract

Renal cell cancer is one of the most widespread oncourological diseases (90% of all the malignant neoplasms in the kidneys) with high mortality. Every year worldwide, approximately 120,000 new cases of renal cell cancer are diagnosed, which is approximately 2% within the structure of the cancer incidence rates, and 65% of the patients are being diagnosed in the developed countries. Nephrectomy is the main method of radical therapy for such patients. In cases of tumor thrombosis of the inferior vena cava, which develops in 25–30% of the cases of renal cell cancer and represents a lethal complication of this disease due to the fragmentation of the thrombotic masses and developing pulmonary embolism, nephrectomy with thrombectomy is indicated. A special category includes the patients with renal cell cancer, complicated by the tumor thrombosis of the inferior vena cava with grades III (thrombus located at the level or above the hepatic veins, but below the diaphragm) and IV (thrombus spreading into the supradiaphragmatic inferior vena cava or into the right atrium) according to the classification by the Mayo Clinic, in which the surgical strategy is accompanied by significantly traumatic manipulations with the liver, the suprahepatic segment of the inferior vena cava, as well as with the heart chambers, suggesting the parallel cardiosurgical intervention. Surgical interventions with this background are accompanied by the complete or the parallel methods of extracorporeal circulation. The initially burdened status of the patient (tumor-related intoxication, anemia, hyperazotemia, in a number of cases thrombosis of the venous system in the lower limbs along with the concomitant abnormalities) and the extent of surgical intervention determine the high risk of complications (up to 93%) and hospital mortality (up to 10%). The preoperative evaluation of the risks of surgery, defining the most favorable tactics for the patient and the thorough preoperative preparation are necessary for the safest course of surgery and for the early rehabilitation of the patient. Currently, there is no unified commonly accepted algorithm adopted for managing such patients, while the developed commonly available standards often have a generalized type, not reflecting the specific features found in the patients with tumor thrombosis of the inferior vena cava. This review attempts to compile the specific features of the anesthetic management in cases of nephrectomy with thrombectomy in patients with renal cell cancer, to describe the main pathophysiological features of the tumor thrombosis of the inferior vena cava, the complications of the perioperative period, the methods for their prevention and treatment. The main directions were provided for the combined diagnostics and treatment, special attention was paid to the multi-disciplinary (urologists, oncologists, cardiovascular and cardiosurgery specialists, anesthesiologists and intensivists) team-based approach to perioperative management of the patients with tumor thrombosis of the inferior vena cava.

About the authors

Oleg V. Strunin

A.V. Vishnevsky National Medical Research Center of Surgery; Peoples’ Friendship University of Russia

Email: struninov@mail.ru
ORCID iD: 0000-0003-2537-954X
SPIN-code: 4734-0837

MD, PhD, Professor

Russian Federation, Moscow; Moscow

Tatiana P. Baitman

A.V. Vishnevsky National Medical Research Center of Surgery; Peoples’ Friendship University of Russia

Author for correspondence.
Email: bit.t@mail.ru
ORCID iD: 0000-0002-3646-1664
SPIN-code: 4684-3230

MD, PhD

Russian Federation, 27 Bolshaya Serpukhovskaya st, Moscow, 115093; Moscow

Maximilyan B. Shainyan

A.V. Vishnevsky National Medical Research Center of Surgery

Email: shnyanmax@gmail.com
ORCID iD: 0000-0002-6226-3573
Russian Federation, Moscow

Vasilii V. Malik

A.V. Vishnevsky National Medical Research Center of Surgery

Email: icefog899@mail.ru
ORCID iD: 0009-0003-6370-3248
Russian Federation, Moscow

Daniil A. Parkhomenko

A.V. Vishnevsky National Medical Research Center of Surgery

Email: parkhomenkod@yandex.ru
ORCID iD: 0009-0008-6460-239X
Russian Federation, Moscow

Dmitry M. Monakov

A.V. Vishnevsky National Medical Research Center of Surgery; Peoples’ Friendship University of Russia

Email: gvkg-monakov@mail.ru
ORCID iD: 0000-0002-9676-1802
Russian Federation, Moscow; Moscow

Alexander A. Gritskevich

A.V. Vishnevsky National Medical Research Center of Surgery; Peoples’ Friendship University of Russia

Email: grek@mail.ru
ORCID iD: 0000-0002-5160-925X
SPIN-code: 2128-7536

MD, PhD

Russian Federation, Moscow; Moscow

Amiran Sh. Revishvili

A.V. Vishnevsky National Medical Research Center of Surgery

Email: amirev@mail.ru
ORCID iD: 0000-0003-1791-9163
SPIN-code: 8181-0826

MD, PhD, Professor, academician of the Russian Academy of Sciences

Russian Federation, Moscow

References

  1. Состояние онкологической помощи населению России в 2023 году / под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. Москва, 2024. 262 с. [Kaprin AD, Starinsky VV, Shakhzadova AO, editors. The state of oncological care for the Russian population in 2023. Moscow; 2024. 262 p. (In Russ.)]
  2. Грицкевич А.А., Ревишвили А.Ш., Зотиков А.Е., и др. Хирургия почечных сосудов. Москва: Фонд «Русские Витязи», 2021. 300 с. [Gritskevich AA, Revishvili ASh, Zotikov AE, et al. Surgery of renal vessels. Moscow: Fond “Russkie Vityazi”; 2021. 300 p. (In Russ.)] EDN: VGKCWU
  3. Topaktaş R, Ürkmez A, Tokuç E, et al. Surgical management of renal cell carcinoma with associated tumor thrombus extending into the inferior vena cava: a 10-year single-center experience. Turk J Urol. 2019; 45(5): 345–350. doi: 10.5152/tud.2019.95826
  4. Carmignani L, Guzzo S, Baudo A, et al. Normothermic cardiopulmonary bypass and beating heart surgery for renal cell cancer with tumor thrombus extension into inferior vena cava and right atrium: a less invasive strategy. World J Urol. 2024;43(1):14. doi: 10.1007/s00345-024-05359-6
  5. Zhao GD, Zhang XP, Hu MG, et al. Step-by-step and orderly lowering of the height of inferior vena cava tumor thrombus is the key to robot-assisted thrombectomy for Mayo III/IV tumor thrombus. BMC Cancer. 2022;22(1):151. doi: 10.1186/s12885-022-09235-7
  6. Вашакмадзе Н.Л. Выбор хирургической тактики у больных раком почки с опухолевым венозным тромбозом ретропеченочного, наддиафрагмального отделов нижней полой вены и правых отделов сердца: Дис. ... канд. мед. наук. Москва, 2024. 167 с. [Vashakmadze NL. Choice of surgical tactics in patients with kidney cancer with tumor venous thrombosis of the retrohepatic, supraphragmatic inferior vena cava and right heart [dissertation]. Moscow; 2024. 167 p. (In Russ.)] EDN: IPVNKD
  7. Tathireddy H, Rice D, Martens K, et al. Breaking down tumor thrombus: current strategies for medical management. Thromb Res. 2023;230:144–151. doi: 10.1016/j.thromres.2023.09.004
  8. Campi R, Barzaghi P, Pecoraro A, et al. Contemporary techniques and outcomes of surgery for locally advanced renal cell carcinoma with focus on inferior vena cava thrombectomy: the value of a multidisciplinary team. Asian J Urol. 2022;3(9):272–281. doi: 10.1016/j.ajur.2022.05.002
  9. Матвеев В.Б., Волкова М.И., Вашакмадзе Н.Л., Стилиди И.С. Техника и непосредственные результаты хирургического лечения больных раком почки с опухолевым венозным тромбозом: опыт клиники урологии НМИЦ онкологии им. Н.Н. Блохина // Онкоурология. 2021. Т. 17, № 2. С. 17–32. [Matveev VB, Volkova MI, Vashakmadze NL, Stilidi IS. Technique and short-term outcomes of surgical treatment in patients with renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinic, N.N. Blokhin National Medical Research Center of Oncology. Onkourologiya = Cancer Urology. 2021;17(2):17–32]. doi: 10.17650/1726-9776-2021-17-2-17-32 EDN: ZDLFGZ
  10. Vergho DC, Loeser A, Kocot A, et al. Tumor thrombus of inferior vena cava in patients with renal cell carcinoma: clinical and oncological outcome of 50 patients after surgery. BMC Res Notes. 2012;5(1):1–9. doi: 10.1186/1756-0500-5-264 EDN: GWXDYR
  11. Wotkowicz C, Libertino JA, Sorcini A, et al. Management of renal cell carcinoma with vena cava and atrial thrombus: minimal access vs median sternotomy with circulatory arrest. BJU Int. 2006;98(2):289–298. doi: 10.1111/j.1464-410X.2006.06272.x
  12. Shen D, Wang H, Wang C, et al. Cumulative sum analysis of the operator learning curve for robot-assisted Mayo Clinic level I-IV inferior vena cava thrombectomy associated with renal carcinoma: a study of 120 cases at a single center. Med Sci Monit. 2020;26:e922987. doi: 10.12659/MSM.922987 EDN: BMEZRT
  13. Zhao X, Li L, Liu Z, et al. Radical nephrectomy and inferior vena cava tumor thrombectomy for Mayo IV tumor thrombus: surgical techniques and clinical experience. J Modern Urology. 2019;24(8):639–644. (In Chin.)
  14. Gwon JG, Cho YP, Han Y, et al. Technical tips for performing suprahepatic vena cava tumor thrombectomy in renal cell carcinoma without using cardiopulmonary bypass. Vasc Specialist Int. 2023;39:23. doi: 10.5758/vsi.230056 EDN: ITQTCL
  15. Jenjitranant P, de Jesus Cendejas-Gomez J, Power A, Power NE. A novel technique for proximal inferior vena cava control during tumor thrombectomy using the COBRA-OS balloon. Can Urol Assoc J. 2024;18(11):E350–E352. doi: 10.5489/cuaj.8772 EDN: GRMZYE
  16. Mata M, Tabbara MM, Alvarez A, et al. Renal cell carcinoma with an “uncoiling” tumor thrombus: intraoperative shift from level III to level IV. World J Surg Oncol. 2024;22(1):76. doi: 10.1186/s12957-024-03355-z EDN: EVGNTR
  17. Lee SA, Jang H, Han Y, et al. Clinical outcomes of venous tumor thrombectomy in renal cell carcinoma. J Vasc Surg Venous Lymphat Disord. 2025;13(6):102290. doi: 10.1016/j.jvsv.2025.102290
  18. Chen S, Lu L, Zheng X, et al. Case report: anesthetic management for removal of tumor thrombus in the inferior vena cava and pulmonary artery in renal cell carcinoma. Front Oncol. 2024;14:1372625. doi: 10.3389/fonc.2024.1372625 EDN: HPJDJR
  19. Tabbara MM, González J, Ciancio G. The surgical evolution of radical nephrectomy and tumor thrombectomy: a narrative review. Ann Transl Med. 2023;11(6):262. doi: 10.21037/atm-22-2877 EDN: NWONYT
  20. Ciancio G, Tabbara MM, Farag A, Salerno T. Renal cell carcinoma with right atrium tumor thrombus treated with radical nephrectomy and tumor thrombectomy in a patient with previous coronary artery bypass graft: a case report. Am J Clin Exp Urol. 2022;10(2):123–128. eCollection 2022.
  21. Williams CM, Myint ZW. The role of anticoagulation in tumor thrombus associated with renal cell carcinoma: a literature review. Cancers (Basel). 2023;15(22):5382. doi: 10.3390/cancers15225382 EDN: MTBDXI
  22. Canadian Cardiovascular Society; American Academy of Family Physicians; American College of Cardiology; American Heart Association; Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008;51(2):210–247. doi: 10.1016/j.jacc.2007.10.001 EDN: YADSTF
  23. Чевина А.А., Полотбек Ж., Рагузина В.Ю., Плотников Г.П. Мультидисциплинарный подход в кардиоонкологии при лечении больных с опухолевым тромбозом нижней полой вены высокого уровня // Хирургия. Журнал им. Н.И. Пирогова. 2023. № 3. С. 43–51. [Chevina AA, Polotbek Zh, Raguzina VYu, Plotnikov GP. Multidisciplinary approach in cardio-oncology for high inferior vena cava thrombosis. Pirogov Russ J Surg. 2023;(3):43–51]. doi: 10.17116/hirurgia202303143 EDN: EMFNAJ
  24. Leewatchararoongjaroen C, Mahavisessin N, Vacharaks K, et al. Prevalence of perioperative pulmonary embolism in patients with renal cell carcinoma undergoing nephrectomy. Heliyon. 2024;10(20):e39407. doi: 10.1016/j.heliyon.2024.e39407 EDN: IPRZFW
  25. Garg H, Kaushik D, Hui D, et al. Haemodynamic changes during radical nephrectomy with inferior vena cava thrombectomy: a pilot study. BJUI Compass. 2022;3(5):327–330. doi: 10.1002/bco2.154 EDN: OYIJLG
  26. Chen K, Wang J, Dai J, et al. Anesthetic management of radical nephrectomy in patients with renal cell carcinoma involving renal vein or inferior vena cava. Tumori. 2019;105(5):411–416. doi: 10.1177/0300891619839295
  27. Fukazawa K, Fong CT, Gologorsky E. Inferior vena cava tumor thrombus dynamics and perioperative pulmonary embolism: a single-center experience. J Cardiothorac Vasc Anesth. 2019;33(10):2728–2734. doi: 10.1053/j.jvca.2019.03.011
  28. Zhang G, Palacios R, Hasoon J, et al. Anesthetic management of a patient with renal cell carcinoma-associated venous thrombosis and massive transfusion. Orthop Rev (Pavia). 2024;16:122538. doi: 10.52965/001c.122538 EDN: MRCOOL
  29. Вarnwal NK, Bhaskar VS, Jain KL. High thoracic epidural anesthesia and dexmedetomidine for awake off-pump coronary artery bypass grafting: a feasible option for patients with severe pulmonary disease. Ann Card Anaesth. 2023;26(3):321–324. doi: 10.4103/aca.aca_153_22
  30. Kumar K, Horner F, Aly M, et al. Why do thoracic epidurals fail? A literature review on thoracic epidural failure and catheter confirmation. World J Crit Care Med. 2024;13(3):94157. doi: 10.5492/wjccm.v13.i3.94157 EDN: SBEMYZ
  31. Ingram A, Harper M. The health economic benefits of perioperative patient warming for prevention of blood loss and transfusion requirements as a consequence of inadvertent perioperative hypothermia. J Perioperative Pract. 2018;28:215–222. doi: 10.1177/1750458918776558
  32. Shenkman B, Budnik I, Einav Y, et al. Model of trauma-induced coagulopathy including hemodilution, fibrinolysis, acidosis, and hypothermia: impact on blood coagulation and platelet function. J Trauma Acute Care Surg. 2017;82(2):287–292. doi: 10.1097/TA.0000000000001282 EDN: YUYHZT
  33. Mitrophanov AY, Szlam F, Sniecinski RM, et al. Controlled multifactorial coagulopathy: effects of dilution, hypothermia, and acidosis on thrombin generation in vitro. J Anesth Analgesia. 2020;130(4):1063–1076. doi: 10.1213/ANE.0000000000004479 EDN: ZUPAFS
  34. Phan V, Tran P, Nguyen D. Anesthetic management of renal tumor with level 3 inferior vena cava extension at a university hospital in vietnam: a case report. Case Rep Oncol. 2025;18(1):120–129. doi: 10.1159/000542962 EDN: IGPSUV
  35. Волкова М.И., Феоктистов П.И., Бегалиев А.К., и др. Влияние трансфузии донорских и аутоэритроцитов на онкологические результаты хирургического лечения больных раком почки с опухолевым венозным тромбозом // Современная онкология. 2023. Т. 25, № 1. С. 133–139. [Volkova MI, Feoktistov PI, Begaliev AK, et al. Effect of transfused donor and autoerythrocytes on the oncological outcomes of surgical treatment in patients with renal cell carcinoma with tumor-related venous thrombosis: observational study. J Modern Oncology. 2023;25(1):133–139] doi: 10.26442/18151434.2023.1.202103 EDN: GUAKRX
  36. Yano D, Yokoyama Y, Tokuda Y, et al. Multidisciplinary surgical approach for renal cell carcinoma with inferior vena cava tumor thrombus. Surg Today. 2022;52(7):1016–1022. doi: 10.1007/s00595-021-02415-1 EDN: QBPBRS
  37. Zhao H, Huang Q, Jia T, et al. Research advances of circulatory bypass technology in surgical treatment of renal cell carcinoma with inferior vena cava tumor thrombus. Acad J Chin Pla Med School. 2024;45(3):315–319. doi: 10.12435/j.issn.2095-5227.2023.136
  38. He W, Cong Z, Liu Y, et al. A novel technique for avoidance of sternotomy, diaphragmic incision and cardiopulmonary bypass during cavoatrial tumor thrombectomy for renal cell carcinoma with intraatrial tumor thrombus: a case series at a single center. BMC Surg. 2023;23(1):252. doi: 10.1186/s12893-023-02156-7 EDN: GVFSYL
  39. Liu Z, Tang S, Tian X, et al. Foley catheter-assisted six-step thrombectomy technique in the surgical management of renal cell carcinoma with Mayo level II to IV tumor thrombus. J Int Med Res. 2019;47(5):2104–2115. doi: 10.1177/0300060519836912
  40. Palmer DA, Humphrey JE, Fredrick A, et al. Endovascular removal of intracardiac thrombus prior to radical nephrectomy and inferior vena cava thrombectomy. Urology. 2016;96:85–86. doi: 10.1016/j.urology.2016.07.020
  41. Хенсли Ф.А., Мартин Д.Е., Грэвли Г.П. Практическая кардиоанестезиология. Пер. с англ. под ред. А.А. Бунятяна. 5-е изд. Москва: Медицинское информационное агентство, 2017. 1084 с. [Hensley FA, Martin DE, Grevli GP. Practical cardiac anesthesiology. Trans. from English ed. by A.A. Bunyatyan. 5nd ed. Moscow: Medicinskoe informacionnoe agentstvo; 2017. 1084 р. (In Russ.)]
  42. Goksedef D, Omeroglu SN, Balkanay OO, et al. Hemolysis at different vacuum levels during vacuum-assisted venous drainage: a prospective randomized clinical trial. Thorac Cardiovasc Surg. 2012;60(40):262–268. doi: 10.1055/s-0031-1280019
  43. Soliman R, Fouad E, Belghith M, Abdelmageed T. Conventional hemofiltration during cardiopulmonary bypass increases the serum lactate level in adult cardiac surgery. Ann Card Anaesth. 2016;19(1):45–51. doi: 10.4103/0971-9784.173019 EDN: YDCULW
  44. Дворянчикова В.А., Тимашков Д.А., Пасечник И.Н., и др. Особенности проведения анестезии и экстракорпорального кровообращения при гибридной операции тромбэктомии из ветвей легочной артерии и нижней полой вены // Кремлевская медицина. Клинический вестник. 2019. № 4. С. 173–179. [Dvoryanchikova VA, Timashkov DA, Pasechnik IN, et al. Specifics of anesthesia and extracorporeal circulation during the hybrid operative thrombectomy from pulmonary artery branches and inferior vena cava: case report. Kremlin Medicine. Clinical Bulletin. 2019;(4):173–179]. doi: 10.26269/sa3p-9j16 EDN: DWJUZH
  45. Hua YB, Li X, Wang DX. Prevalence and risk factors of myocardial and acute kidney injury following radical nephrectomy with vena cava thrombectomy: a retrospective cohort study. BMC Anesthesiol. 2021;21(1):1–13. doi: 10.1186/s12871-021-01462-y EDN: SCBSPS
  46. Ishiyama Y, Kondo T, Tachibana H, et al. Surgical outcomes for older patients with renal cell carcinoma and inferior vena cava thrombus. Urol Oncol. 2022;3(40):110.e11–110.e18. doi: 10.1016/j.urolonc.2021.12.013 EDN: BNNYKD
  47. Hatzakorzian R, Blotsky A, Moore A, et al. Migration of an inferior vena cava tumor thrombus during renal cell carcinoma resection. Case Rep Anesthesiol. 2023;2023:6632030. doi: 10.1155/2023/6632030 EDN: PVHFIM
  48. Farge D, Frere C, Connors JM, et al. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol. 2022;23(7):e334–e347. doi: 10.1016/S1470-2045(22)00160-7
  49. Toren P, Abouassaly R, Timilshina N, et al. Results of a national population-based study of outcomes of surgery for renal tumors associated with inferior vena cava thrombus. Urology. 2013;82(3):572–577. doi: 10.1016/j.urology.2013.04.054
  50. Frölich UM, Leucht K, Grimm MO, Foller S. Complications of tumor nephrectomy with and without tumor thrombus in the vena cava, recorded with the clavien-dindo classification: a matched-pair analysis. Cancers (Basel). 2024;16(20):3523. doi: 10.3390/cancers16203523 EDN: FQZYAK
  51. Hanquiez P, Neuville P, Robin J, et al. Outcomes after radical nephrectomy with vena cava thrombectomy using multidisciplinary approach: a single center experience. Fr J Urol. 2024;34(7-8):102657. doi: 10.1016/j.fjurol.2024.102657 EDN: EWLFEM
  52. Huang Z, Liu Z, Zhuo L, et al. Risk factors for renal insufficiency and survival implications after radical nephrectomy and thrombectomy in renal cell carcinoma with tumor thrombus: a systematic review. BMC Urol. 2025;25(1):20. doi: 10.1186/s12894-024-01664-9 EDN: VBOOQU
  53. Taweemonkongsap T, Suk-Ouichai C, Jitpraphai S, et al. Survival benefits after radical nephrectomy and IVC thrombectomy of renal cell carcinoma patients with inferior vena cava thrombus. Heliyon. 2024;10(4):e25835. doi: 10.1016/j.heliyon.2024.e25835 EDN: PLWNHM
  54. Gaillard V, Tricard T, Addeo P, et al. Conservative management of inferior vena cava thrombus during nephrectomy for renal cell carcinoma. Urol Oncol. 2024;42(12):452.e21–452.e28. doi: 10.1016/j.urolonc.2024.08.018 EDN: TOJUDZ
  55. Tripathy TP, Patel R, Behera S, et al. The change in liver volume after inferior vena cava and/or hepatic vein venoplasty in patients with budd chiari syndrome with at least one patent hepatic vein presenting with ascites. J Clin Exp Hepatol. 2025;15(3):102486. doi: 10.1016/j.jceh.2024.102486 EDN: PZHAPO
  56. Schick MA, Kashyap S, Collier SA, Meseeha M. Small bowel obstruction. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».